In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
[摘要] We would like to thank Dr. Fakheri and colleagues for their extremely helpful comments on our recent review of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs).
[发布日期] [发布机构]
[效力级别] [学科分类] 卫生学
[关键词] [时效性]
